Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01594645

The Clinical Impact of Selecting Acrosome Reacted Spermatozoa for ICSI

The Impact of Selecting Acrosome Reacted Spermatozoa for ICSI- a Prospective RCT

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years – 38 Years
Healthy volunteers
Not accepted

Summary

Presently spermatozoa for ICSI are selected based on morphology and motion, without determining if acrosome reaction (AR) had occurred during sperm preparation or not. Although not critical if the sperm is injected into the ooplasm, the occurrence of AR might might be an indicator of better spermatozoon quality and implantation potential, especially in severe OTA cases. It is impossible with conventional plain optic microscopy used in IVF units to determine in vivo (without fixation) if AR has occurred, and as a result spermatozoa are injected randomly. It is readily possible to distinguish AR+ from AR- spermatozoa using polarized light microscopy due to different bifriengance. In this study the investigators seek to determine, by a prospective RCT, if selecting only acrosome reacted spermatozoa, in severe OTA cases, will improve the outcome of ICSI and the entire IVF process.

Detailed description

A prospective RCT to determine the effect of polscope based spermatozoa selection for ICSI.

Conditions

Interventions

TypeNameDescription
PROCEDURESperm selection by conventional / polarized light microscopySelecting spermatozoa for ICSI using conventional and polarized light microscopy

Timeline

Start date
2012-09-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2012-05-09
Last updated
2015-08-20

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01594645. Inclusion in this directory is not an endorsement.